{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:27:46Z","timestamp":1786649266592,"version":"build-2736575974"},"reference-count":46,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Diabetes mellitus (DM) is a metabolic disorder that leads to the destruction of various tissues including bones. The pathogenesis of osteoporosis (OP) varies in DM due to many specific factors. DM increases the risk of fracture as well as post-fracture mortality. It is because of this fact that OP treatment should not be neglected in patients with DM. OP therapy comprises anabolic as well as anti-resorptive agents. Primary OP as observed in post-menopausal women is associated with high bone turnover, whereas OP in DM is a disease of low bone turnover. Therefore, anabolic agents seem to be quite promising in cases of OP in DM. Although the anti-fracture efficacy of these drugs is proven beyond any doubt in the general population without DM, evidence in persons with DM is limited. Among the anabolic agents, teriparatide has the most evidence in favor of its efficacy and safety in persons with DM. Studies evaluating other anabolic agents such as abaloparatide and romosozumab in diabetic osteopathy are scarce in the literature. Future studies specifically in both type 1 and type 2 DM populations are needed to evaluate the effects of osteoanabolic agents.<\/jats:p>","DOI":"10.4103\/ijem.ijem_81_24","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T09:05:47Z","timestamp":1740733547000},"page":"32-38","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Role of Anabolic Anti-Osteoporosis Therapy in Diabetes Subjects"],"prefix":"10.4103","volume":"29","author":[{"given":"Harsh","family":"Durgia","sequence":"first","affiliation":[{"name":"Dr. Harsh\u2019s Endocrine and Diabetes Center, Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajan","family":"Palui","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, The Mission Hospital, Durgapur, West Bengal, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayaprakash","family":"Sahoo","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadishkumar","family":"Kamalanathan","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dukhabandhu","family":"Naik","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Puducherry, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,2,28]]},"reference":[{"key":"R1-20250228","doi-asserted-by":"crossref","first-page":"107843","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"R2-20250228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12902-022-01260-8","article-title":"Prevalence of osteoporosis in patients with diabetes mellitus: A systematic review and meta-analysis of observational studies","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"R3-20250228","doi-asserted-by":"crossref","first-page":"115457","DOI":"10.1016\/j.bone.2020.115457","article-title":"The risk of hip and non-vertebral fractures in type 1 and type 2 diabetes: A systematic review and meta-analysis update","volume":"137","author":"Vilaca","year":"2020","journal-title":"Bone"},{"key":"R4-20250228","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00198-019-05122-3","article-title":"The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: A multi-state cohort analysis","volume":"30","author":"Teb\u00e9","year":"2019","journal-title":"Osteoporos Int"},{"key":"R5-20250228","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: An endocrine society*clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"R6-20250228","doi-asserted-by":"crossref","first-page":"R137","DOI":"10.1530\/EJE-16-0652","article-title":"MECHANISMS IN ENDOCRINOLOGY: Diabetes mellitus, a state of low bone turnover - A systematic review and meta-analysis","volume":"176","author":"Hygum","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"R7-20250228","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1210\/jc.2012-1546","article-title":"Circulating osteogenic precursor cells in type 2 diabetes mellitus","volume":"97","author":"Manavalan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"R8-20250228","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/dme.12734","article-title":"Type 1 diabetes and risk of fracture: Meta-analysis and review of the literature","volume":"32","author":"Shah","year":"2015","journal-title":"Diabet Med"},{"key":"R9-20250228","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2337\/dc15-0783","article-title":"Type 1 diabetes is associated with an increased risk of fracture across the life span: A population-based cohort study using The Health Improvement Network (THIN)","volume":"38","author":"Weber","year":"2015","journal-title":"Diabetes Care"},{"key":"R10-20250228","doi-asserted-by":"crossref","first-page":"e024067","DOI":"10.1136\/bmjopen-2018-024067","article-title":"Diabetes mellitus and the risk of fractures at specific sites: A meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"R11-20250228","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes--A meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"R12-20250228","doi-asserted-by":"crossref","first-page":"R127","DOI":"10.1530\/EJE-15-0820","article-title":"Mechanisms in endocrinology: Mechanisms and evaluation of bone fragility in type 1 diabetes mellitus","volume":"174","author":"Hough","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"R13-20250228","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/BF03343726","article-title":"Osteopenia in insulin-dependent diabetes mellitus;prevalence and aspects of pathophysiology","volume":"23","author":"Kemink","year":"2000","journal-title":"J Endocrinol Invest"},{"key":"R14-20250228","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1359\/jbmr.2001.16.5.958","article-title":"Amylin and bone metabolism in streptozotocin-induced diabetic rats","volume":"16","author":"Horcajada-Molteni","year":"2001","journal-title":"J Bone Miner Res"},{"key":"R15-20250228","first-page":"455","article-title":"Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation","volume":"28","author":"Hie","year":"2011","journal-title":"Int J Mol Med"},{"key":"R16-20250228","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1002\/jcb.20842","article-title":"Chronic hyperglycemia modulates osteoblast gene expression through osmotic and non-osmotic pathways","volume":"99","author":"Botolin","year":"2006","journal-title":"J Cell Biochem"},{"key":"R17-20250228","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00198-014-2631-7","article-title":"High serum pentosidine but not esRAGE is associated with prevalent fractures in type 1 diabetes independent of bone mineral density and glycaemic control","volume":"25","author":"Neumann","year":"2014","journal-title":"Osteoporos Int"},{"key":"R18-20250228","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s13300-020-00964-1","article-title":"Diabetes and Bone Fragility","volume":"12","author":"Romero-D\u00edaz","year":"2021","journal-title":"Diabetes Ther"},{"key":"R19-20250228","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s10654-012-9674-x","article-title":"Association between bone mineral density and type 2 diabetes mellitus: A meta-analysis of observational studies","volume":"27","author":"Ma","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"R20-20250228","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R21-20250228","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: An emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"issue":"(Suppl 1)","key":"R22-20250228","first-page":"S52","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"key":"R23-20250228","doi-asserted-by":"crossref","first-page":"17455057241231387","DOI":"10.1177\/17455057241231387","article-title":"Use of Fracture Risk Assessment Tool in clinical practice and Fracture Risk Assessment Tool future directions","volume":"20","author":"Zerikly","year":"2024","journal-title":"Womens Health (Lond)"},{"key":"R24-20250228","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00198-019-05053-z","article-title":"Association between trabecular bone score and type 2 diabetes: A quantitative update of evidence","volume":"30","author":"Ho-Pham","year":"2019","journal-title":"Osteoporos Int"},{"key":"R25-20250228","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-023-06935-z","article-title":"Trabecular bone score in adults with type 1 diabetes: A meta-analysis","volume":"35","author":"Bhattacharya","year":"2024","journal-title":"Osteoporos Int"},{"key":"R26-20250228","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1093\/ageing\/afw140","article-title":"Diabetes mellitus and risk of falls in older adults: A systematic review and meta-analysis","volume":"45","author":"Yang","year":"2016","journal-title":"Age Ageing"},{"key":"R27-20250228","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: A meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"R28-20250228","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1111\/obr.12885","article-title":"The use of metformin, insulin, sulphonylureas, and thiazolidinediones and the risk of fracture: Systematic review and meta-analysis of observational studies","volume":"20","author":"Hidayat","year":"2019","journal-title":"Obes Rev"},{"key":"R29-20250228","doi-asserted-by":"crossref","first-page":"e2130762","DOI":"10.1001\/jamanetworkopen.2021.30762","article-title":"Association of sodium-glucose cotransporter\u20132 inhibitors with fracture risk in older adults with type 2 diabetes","volume":"4","author":"Zhuo","year":"2021","journal-title":"JAMA Network Open"},{"key":"R30-20250228","doi-asserted-by":"crossref","first-page":"17353","DOI":"10.1038\/s41598-019-52224-3","article-title":"Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes","volume":"9","author":"Pacicca","year":"2019","journal-title":"Sci Rep"},{"key":"R31-20250228","first-page":"719","article-title":"Comparison of insulin-like growth factor-1 and sclerostin levels between premenopausal women with and without diabetes mellitus","volume":"16","author":"Sylvawani","year":"2021","journal-title":"J Taibah Univ Med Sci"},{"key":"R32-20250228","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bone.2018.08.007","article-title":"Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)","volume":"120","author":"W\u0119drychowicz","year":"2019","journal-title":"Bone"},{"key":"R33-20250228","doi-asserted-by":"crossref","first-page":"e371","DOI":"10.1210\/clinem\/dgad043","article-title":"Low bone turnover associates with lower insulin sensitivity in newly diagnosed drug-na\u00efve persons with type 2 diabetes","volume":"108","author":"Nasser","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"R34-20250228","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s00223-022-01022-7","article-title":"Determinants of low bone turnover in type 2 diabetes-the role of PTH","volume":"111","author":"Vavanikunnel","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"R35-20250228","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11914-023-00833-3","article-title":"Efficacy of osteoporosis medications in patients with type 2 diabetes","volume":"22","author":"Vilaca","year":"2024","journal-title":"Curr Osteoporos Rep"},{"key":"R36-20250228","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.bone.2016.06.017","article-title":"Teriparatide in patients with osteoporosis and type 2 diabetes","volume":"91","author":"Schwartz","year":"2016","journal-title":"Bone"},{"key":"R37-20250228","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s00198-013-2284-y","article-title":"The Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) study:2-year nonvertebral fragility fracture results","volume":"24","author":"Silverman","year":"2013","journal-title":"Osteoporos Int"},{"key":"R38-20250228","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","article-title":"Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: Integrated analysis of 4 prospective observational studies","volume":"116","author":"Langdahl","year":"2018","journal-title":"Bone"},{"key":"R39-20250228","doi-asserted-by":"crossref","first-page":"481","DOI":"10.3390\/medicina58040481","article-title":"Effect of teriparatide on bone mineral density and trabecular bone score in type 2 diabetic patients with osteoporosis: A retrospective cohort study","volume":"58","author":"Munekawa","year":"2022","journal-title":"Medicina (Kaunas)"},{"key":"R40-20250228","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jbmr.3007","article-title":"PTHrP-derived peptides restore bone mass and strength in diabetic mice: Additive effect of mechanical loading","volume":"32","author":"Maycas","year":"2017","journal-title":"J Bone Miner Res"},{"key":"R41-20250228","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: A randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"R42-20250228","doi-asserted-by":"crossref","first-page":"e10346","DOI":"10.1002\/jbm4.10346","article-title":"Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: A post hoc analysis of the ACTIVE study","volume":"4","author":"Dhaliwal","year":"2020","journal-title":"JBMR Plus"},{"key":"R43-20250228","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.1803","article-title":"Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus","volume":"28","author":"Hamann","year":"2013","journal-title":"J Bone Miner Res"},{"key":"R44-20250228","doi-asserted-by":"crossref","first-page":"e10665","DOI":"10.1002\/jbm4.10665","article-title":"Teriparatide and osteosarcoma risk: History, science, elimination of boxed warning, and other label updates","volume":"6","author":"Krege","year":"2022","journal-title":"JBMR Plus"},{"key":"R45-20250228","doi-asserted-by":"crossref","first-page":"dgaa048","DOI":"10.1210\/clinem\/dgaa048","article-title":"Pharmacological management of osteoporosis in postmenopausal women: An endocrine society guideline update","volume":"105","author":"Shoback","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"R46-20250228","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"}],"container-title":["Indian Journal of Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_81_24","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:51:34Z","timestamp":1786647094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijem.ijem_81_24"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.4103\/ijem.ijem_81_24","relation":{},"ISSN":["2230-8210","2230-9500"],"issn-type":[{"value":"2230-8210","type":"print"},{"value":"2230-9500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"2024-03-11","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-11-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}